Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11367.x/fullpdf
Reference19 articles.
1. Screening and prostate-cancer mortality in a randomized European study;Schroder;N Engl J Med,2009
2. Screening for prostate cancer decreases the risk of developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC);Schröder;Eur Urol,2012
3. Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up;Andriole;J Natl Cancer Inst,2012
4. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results;Roehl;Urol Oncol,2006
5. Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening;Ciatto;BJU Int,2003
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam;European Urology Open Science;2023-05
2. Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy;BMJ Open;2021-05
3. The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy;Investigative and Clinical Urology;2021
4. A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature;Cancers;2019-10-21
5. Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer;BJU International;2019-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3